| 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis DS Ross, HB Burch, DS Cooper, MC Greenlee, P Laurberg, AL Maia, ... Thyroid 26 (10), 1343-1421, 2016 | 2738 | 2016 |
| Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans AL Maia, BW Kim, SA Huang, JW Harney, PR Larsen The Journal of clinical investigation 115 (9), 2524-2533, 2005 | 453 | 2005 |
| The role of thyroid hormone in testicular development and function MS Wagner, SM Wajner, AL Maia The Journal of endocrinology 199 (3), 351, 2008 | 355 | 2008 |
| THEMATIC REVIEW Deiodinases: the balance of thyroid hormone Type 1 iodothyronine deiodinase in human physiology and disease AL Maia, IM Goemann, ELS Meyer, SM Wajner Journal of Endocrinology 209, 283-297, 2011 | 282 | 2011 |
| Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus PW Rosário, LS Ward, GA Carvalho, H Graf, R Maciel, LMZ Maciel, ... Arquivos Brasileiros de Endocrinologia & Metabologia 57, 240-264, 2013 | 260* | 2013 |
| Type 3 lodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme. D Salvatore, SC Low, M Berry, AL Maia, JW Harney, W Croteau, ... The Journal of clinical investigation 96 (5), 2421-2430, 1995 | 249 | 1995 |
| The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus LH Canani, C Capp, JM Dora, ELS Meyer, MS Wagner, JW Harney, ... The Journal of Clinical Endocrinology & Metabolism 90 (6), 3472-3478, 2005 | 234 | 2005 |
| The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves’ hyperthyroidism: one-year follow-up of a prospective, randomized study VA Andrade, JL Gross, AL Maia The Journal of Clinical Endocrinology & Metabolism 86 (8), 3488-3493, 2001 | 220 | 2001 |
| IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells SM Wajner, IM Goemann, AL Bueno, PR Larsen, AL Maia The Journal of clinical investigation 121 (5), 1834-1845, 2011 | 214 | 2011 |
| Adaptive activation of thyroid hormone and energy expenditure AC Bianco, AL Maia, WS da Silva, MA Christoffolete Bioscience reports 25 (3-4), 191-208, 2005 | 184 | 2005 |
| Substitution of cysteine for selenocysteine in type I iodothyronine deiodinase reduces the catalytic efficiency of the protein but enhances its translation MJ Berry, AL Maia, JD Kieffer, JW Harney, PR Larsen Endocrinology 131 (4), 1848-1852, 1992 | 180 | 1992 |
| Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case–control study and meta-analysis JM Dora, WE Machado, J Rheinheimer, D Crispim, AL Maia European Journal of Endocrinology 163 (3), 427-434, 2010 | 176 | 2010 |
| Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population … F Castinetti, XP Qi, MK Walz, AL Maia, G Sansó, M Peczkowska, ... The Lancet Oncology 15 (6), 648-655, 2014 | 175 | 2014 |
| A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene N Toyoda, AM Zavacki, AL Maia, JW Harney, PR Larsen Molecular and cellular biology, 1995 | 173 | 1995 |
| Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10 K Frank‐Raue, LA Rybicki, Z Erlic, H Schweizer, A Winter, I Milos, ... Human mutation 32 (1), 51-58, 2011 | 158 | 2011 |
| RET Codon 634 Mutations in Multiple Endocrine Neoplasia Type 2: Variable Clinical Features and Clinical Outcome MK Puñales, H Graf, JL Gross, AL Maia The Journal of Clinical Endocrinology & Metabolism 88 (6), 2644-2649, 2003 | 152 | 2003 |
| Radiofrequency ablation and related ultrasound‐guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus … LA Orloff, JE Noel, BC Stack Jr, MD Russell, P Angelos, JH Baek, ... Head & neck 44 (3), 633-660, 2022 | 151 | 2022 |
| Increased expression of vascular endothelial growth factor and its receptors, VEGFR-1 and VEGFR-2, in medullary thyroid carcinoma C Capp, SM Wajner, DR Siqueira, BA Brasil, L Meurer, AL Maia Thyroid 20 (8), 863-871, 2010 | 149 | 2010 |
| Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives L Ceolin, MA da Silveira Duval, AF Benini, CV Ferreira, AL Maia Endocrine-related cancer 26 (9), R499-R518, 2019 | 128 | 2019 |
| New insights toward the acute non-thyroidal illness syndrome SM Wajner, AL Maia Frontiers in Endocrinology 3, 8, 2012 | 120 | 2012 |
Jose Miguel DoraHospital de Clínicas de Porto Alegre/Universidade Federal do Rio Grande do Sul在 hcpa.edu.br 的电子邮件经过验证
